Sotyktu (deucravacitinib)
pCPA File Number:
22432
Negotiation Status:
Active Negotiation
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
Bristol-Myers Squibb Company
CADTH Project Number:
SR0756-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable